Eden Prairie, United States
Evergen, previously known as Collagen Solutions, operates under the guiding mantra, "Materials for Life." As a segment of RTI Surgical Company, Evergen has established itself as a benchmark entity in the Biotechnology and Medical Devices sectors. Founded in 2014, the company has positioned itself as a pivotal supplier and innovator of medical-grade collagen and other critical biomaterials.
The firm's impressive proficiency spans the development and manufacturing of engineered tissue scaffolds and biomaterials-based medical devices, which serve diverse applications including orthopedics, cardiovascular, dental, and more. Headquartered in the United States, Evergen continues to bolster its innovation-driven agenda through strategic investments.
Their latest funding milestone was a £12.00M Post-IPO Equity investment in February 2017, led by Norginer Ventures. With this backing, Evergen is poised to enhance its footprint in the rapidly growing regenerative medicine landscape.
